Results 121 to 130 of about 110,820 (315)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
A Rare Case of Synchronous Primary Uterine Cervical Minimal Deviation Adenocarcinoma and low-grade appendiceal mucinous neoplasm [PDF]
, 2023 Junmiao Xiang, Zhuhua Cai, Sisi Yu
openalex +1 more source
VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix
Cancer Science, EarlyView.Small cell neuroendocrine carcinoma of the cervix (SCNEC), a rare but aggressive cancer, consistently exhibited high VRK1 expression. VRK1 knockdown significantly suppressed xenograft tumor growth by inducing mitochondrial dysfunction. These findings highlighted VRK1 as a potential therapeutic target for SCNEC.
Mariya Kobayashi +16 more
wiley +1 more source
Focal Spot, Fall/Winter 2002/2003 [PDF]
, 2003 https://digitalcommons.wustl.edu/focal_spot_archives/1092/thumbnail ...
core +1 more source
The Tohoku Journal of Experimental Medicine, 2008 There has been an increased incidence of cervical cancer among young women, and they tend to have a poor prognosis due to unknown reasons. We hypothesize growth hormone (GH) receptor (GHR) may be involved in the proliferation of cervical carcinoma, because GH-related neoplasms arise in various organs and the amount of GH secretion may be different ...
Reiko, Dehari +3 more
openaire +3 more sources
Cancer Science, EarlyView.This study is the first to identify a novel neutrophil subpopulation, N4, that is closely associated with the progression of cervical cancer. Characterized by high PLAU expression and specific interactions with tumor cells, N4 neutrophils were shown to promote tumor growth and immune modulation.
Ze Wang +7 more
wiley +1 more source
Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Colorectal Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Carcinoma, Renal Cell,Uterine Cervical Neoplasms, Date of authorisation: 14/02/2019, Revision: 1, Status: Authorised [PDF]
, 2019 Kernel Networks Inc.
openalex +1 more source
Large Cell Neuroendocrine Carcinoma of the Cervix With Extensive Metastases
The Kaohsiung Journal of Medical Sciences, EarlyView.
Di‐Ping Yu, Li‐Mei Sun
wiley +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Background Metformin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) may reduce the risk of adiposity‐related cancers in patients with type 2 diabetes (T2D). The potential synergistic effects of these treatments on cancer incidence remain unclear, considering their distinct biological mechanisms and their associated effects on body ...
Alex E. Henney +6 more
wiley +1 more source